Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Inspire Medical Systems Inc’s stock clocked out at $183.99, up 1.66% from its previous closing price of $180.99. In other words, the price has increased by $1.66 from its previous closing price. On the day, 1.49 million shares were traded. INSP stock price reached its highest trading level at $185.77 during the session, while it also had its lowest trading level at $170.0201.
Ratios:
To gain a deeper understanding of INSP’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.37 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 60.51. For the most recent quarter (mrq), Quick Ratio is recorded 6.22 and its Current Ratio is at 7.13. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 20, 2024, Upgraded its rating to Buy and sets its target price to $255 from $220 previously.
On May 08, 2024, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $265 to $225.
On April 19, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $285.RBC Capital Mkts initiated its Outperform rating on April 19, 2024, with a $285 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 11 ’25 when JOHN RONDONI bought 583 shares for $170.49 per share.
Rondoni John sold 58 shares of INSP for $12,470 on Jan 07 ’25. The Chief Technology Officer now owns 11,322 shares after completing the transaction at $215.00 per share. On Jan 07 ’25, another insider, JOHN RONDONI, who serves as the Officer of the company, bought 58 shares for $215.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 5458872832 and an Enterprise Value of 5038051840. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 106.14, and their Forward P/E ratio for the next fiscal year is 57.08. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.87 while its Price-to-Book (P/B) ratio in mrq is 7.93. Its current Enterprise Value per Revenue stands at 6.668 whereas that against EBITDA is 274.031.
Stock Price History:
The Beta on a monthly basis for INSP is 1.48, which has changed by -0.05685252 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $257.40, while it has fallen to a 52-week low of $123.00. The 50-Day Moving Average of the stock is -2.88%, while the 200-Day Moving Average is calculated to be 0.84%.
Shares Statistics:
It appears that INSP traded 520.92K shares on average per day over the past three months and 450090 shares per day over the past ten days. A total of 29.74M shares are outstanding, with a floating share count of 29.20M. Insiders hold about 2.56% of the company’s shares, while institutions hold 113.55% stake in the company. Shares short for INSP as of 1736899200 were 2284016 with a Short Ratio of 4.38, compared to 1734048000 on 2319952. Therefore, it implies a Short% of Shares Outstanding of 2284016 and a Short% of Float of 8.75.
